疫苗时代成人侵袭性肺炎链球菌疾病中持续存在的血清型3和19A:头孢曲松敏感性的血清型依赖性差异
一项前瞻性多中心侵袭性肺炎链球菌疾病(IPD)监测研究纳入2019年7月至2021年6月≥19岁成人,收集160例IPD病例,对116株分离株进行血清分型和药敏检测。PCV13和PPSV23血清型分别占32.8%和56.0%,血清型3(13.8%)和19A(9.5%)最常见;32.5%的分离株对头孢曲松不敏感,血清型11A、11E和19A的不敏感率分别为80%、100%和81.8%,多与ST166和ST320相关。
要点
- 成人IPD中PCV13血清型占32.8%,血清型3和19A最常见。
- 32.5%的侵袭性肺炎链球菌分离株对头孢曲松不敏感。
- 血清型11A、11E和19A的头孢曲松不敏感率高,多与ST166和ST320相关。
核心结论
- PCV血清型尤其是3和19A仍在成人IPD中流行,提示老年人及慢性病患者可能需要个体化PCV13免疫。
- 侵袭性肺炎链球菌分离株的头孢曲松不敏感率显著高。
研究设计与样本
- 前瞻性多中心IPD监测研究,纳入2019年7月至2021年6月≥19岁成人,共收集160例IPD病例,平均年龄65.1岁(男性72.5%)。
- 对116株可获得的肺炎链球菌分离株进行抗生素敏感性试验、血清型鉴定和多 locus 序列分型(MLST)。
主要发现
- PCV13血清型占32.8%(n=38),PPSV23血清型占56.0%(n=65)。
- 血清型3(13.8%)和19A(9.5%)是最常见的致病血清型,其次为血清群11(6.9%)、23A(6.9%)、10A(4.3%)和15B(4.3%)。
- 32.5%的侵袭性肺炎链球菌分离株对头孢曲松不敏感。
- 血清型11A、11E和19A的头孢曲松不敏感率分别为80%、100%和81.8%,与序列型(ST)166和ST320相关。
- 大多数血清型3分离株对头孢曲松敏感,与ST180相关。
临床怎么用
- 作者认为,PCV血清型尤其是3和19A仍在成人IPD中流行,提示老年人及慢性病患者可能需要个体化PCV13免疫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive pneumococcal disease (IPD) is associated with substantial morbidity and mortality in children and elderly populations. Serotype distribution and antibiotic susceptibility of IPD isolates are changing with the implementation of pneumococcal vaccination and increasing antibiotic use worldwide. We aimed to determine serotype distribution, antibiogram, and molecular epidemiology of pneumococci in the late stage of PCV13 era. METHODS: Prospective multicenter IPD surveillance study was conducted for adults aged ≥ 19 years from July 2019 to June 2021. Clinical and epidemiologic data were collected. In addition, antibiotic susceptibility test, serotype identification and multi-locus sequence typing (MLST) was taken for pneumococcal isolates. RESULTS: A total of 160 IPD cases were collected with mean age of 65.1 years (male, 72.5%). Serotyping was taken for 116 available pneumococcal isolates. PCV13 and PPSV23 serotypes were 32.8% (n = 38) and 56.0% (n = 65), respectively. Serotype 3 (13.8%) and 19A (9.5%) were the most common causative agents of IPD, followed by serogroup 11 (6.9%), 23A (6.9%), 10A (4.3%), and 15B (4.3%). Notably, 32.5% of invasive pneumococcal isolates were non-susceptible to ceftriaxone. Serotypes 11A, 11E and 19A pneumococci showed high ceftriaxone non-susceptible rate (80%, 100% and 81.8% respectively), and they were related to sequence type (ST) 166 and ST320. In comparison, most serotype 3 isolates were ceftriaxone susceptible and related to ST180. CONCLUSIONS: PCV serotypes, especially 3 and 19A, are still prevalent in adult IPDs, suggesting that individual PCV13 immunization would be necessary for the elderly people and chronically ill patients. Ceftriaxone non-susceptible rate was remarkably high in invasive pneumococcal isolates.
引用
- Yoon JG, Jang AY, Kim MJ, et al. Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility. Vaccine. 2022. PMID: 35282927. doi:10.1016/j.vaccine.2022.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。